UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 45

Sortiert nach

Stress in the onset and aggravation of learning disabilities

Developmental review, 2021-09, Vol.61, p.100968, Article 100968

2021

Volltextzugriff (PDF)

The role of epigenetic mechanisms in the long‐term effects of early‐life adversity and mother–infant relationship on physiology and behavior of offspring in laboratory rats and mice

Developmental psychobiology, 2024-04, Vol.66 (3), p.e22479-n/a

2024

Volltextzugriff (PDF)

Effects of early social deprivation on epigenetic statuses and adaptive behavior of young children: A study based on a cohort of institutionalized infants and toddlers

PloS one, 2019-03, Vol.14 (3), p.e0214285-e0214285

2019

Volltextzugriff (PDF)

Neuroendocrine and autonomic stress systems activity in young adults raised by mothers with mental health and substance abuse problems: A prospective cohort study

Developmental psychobiology, 2021-12, Vol.63 (8), p.e22213-n/a

2021

Volltextzugriff (PDF)

Effects of Early-Life Stress and HDAC Inhibition on Maternal Behavior in Mice

Behavioral neuroscience, 2019-02, Vol.133 (1), p.39-49

2019

Volltextzugriff (PDF)

Associations between telomere length, glucocorticoid receptor gene DNA methylation, volume of stress-related brain structures, and academic performance in middle-school-age children

Comprehensive Psychoneuroendocrinology (Online), 2024-02, Vol.17, p.100223-100223, Article 100223

2024

Volltextzugriff (PDF)

Endogenous Oxytocin and Human Social Interactions: A Systematic Review and Meta-Analysis

Psychological bulletin, 2023-09, Vol.149 (9-10), p.549-579

2023

Volltextzugriff (PDF)

Objective Assessment of Temperament in Temperamentally Vulnerable Children: Role in the Studies on Their Stress Levels

New directions for child and adolescent development, 2020-01, Vol.2020 (169), p.97-115

2020

Volltextzugriff (PDF)

Antitumor activity of MLN8054, an orally active small-molecule inhibitor of Aurora A kinase

Proceedings of the National Academy of Sciences - PNAS, 2007-03, Vol.104 (10), p.4106-4111

2007

Volltextzugriff (PDF)

Male pseudohermaphroditism: A case study of 46,XY disorder of sexual development using whole‐exome sequencing

Clinical case reports, 2020-12, Vol.8 (12), p.2889-2894

2020

Volltextzugriff (PDF)

Internet communication: architecture and typology of digital folklore

IOP conference series. Materials Science and Engineering, 2020-07, Vol.890 (1), p.12212

2020

Volltextzugriff (PDF)

842 Exosome mediated reprogramming of tumor associated macrophages by exoASO-STAT6 for the treatment of hepatocellular carcinoma (HCC)

Journal for immunotherapy of cancer, 2021-11, Vol.9 (Suppl 2), p.A883-A883

2021

Volltextzugriff (PDF)

Exosome-mediated genetic reprogramming of tumor-associated macrophages by exoASO-STAT6 leads to potent monotherapy antitumor activity

Science advances, 2022-02, Vol.8 (7), p.eabj7002-eabj7002

2022

Volltextzugriff (PDF)

An ErbB3 Antibody, MM-121, Is Active in Cancers with Ligand-Dependent Activation

Cancer research (Chicago, Ill.), 2010-03, Vol.70 (6), p.2485-2494

2010

Volltextzugriff (PDF)

Abstract 1792: Engineered exosome- mediated STAT6 knockdown in tumor associated macrophages (TAMs) results in potent single agent activity in a hepatocellular carcinoma (HCC) model

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.1792-1792

2021

Volltextzugriff (PDF)

Design of BET Inhibitor Bottlebrush Prodrugs with Superior Efficacy and Devoid of Systemic Toxicities

Journal of the American Chemical Society, 2021-03, Vol.143 (12), p.4714-4724

2021

Volltextzugriff (PDF)

Abstract 5696: Genetic reprogramming of TAMs by engineered exosomes results in potent single agent anti-tumor activity

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.5696-5696

2020

Volltextzugriff (PDF)

Enhanced Targeting of the EGFR Network with MM-151, an Oligoclonal Anti-EGFR Antibody Therapeutic

Molecular cancer therapeutics, 2015-07, Vol.14 (7), p.1625-1636

2015

Volltextzugriff (PDF)

Antibody Drug Conjugates Targeted to CD45 or CD117 Enable Allogeneic Hematopoietic Stem Cell Transplantation in Animal Models

Blood, 2018-11, Vol.132 (Supplement 1), p.3324-3324

2018

Volltextzugriff (PDF)

Abstract LB-243: The ErbB3-targeting antibody MM-121 (seribantumab) reverses heregulin-driven resistance to multiple chemotherapies on tumor cell growth

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.LB-243-LB-243

2015

Volltextzugriff (PDF)

Abstract 2148: MM-151 elicits broad and unique inhibition of cells harboring EGFR extracellular domain mutations — results of multiscale experiments with genome-edited cell lines

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.2148-2148

2016

Volltextzugriff (PDF)

Abstract LB-C25: Inhibition of ERBB3 with MM-121, IGF1-R with MM-141 or Met with MM-131 increases the activity of EGFR inhibitor MM-151 in colorectal cancer models expressing multiple resistance ligands

Molecular cancer therapeutics, 2015-12, Vol.14 (12_Supplement_2), p.LB-C25-LB-C25

2015

Volltextzugriff (PDF)

Abstract 3508: Exosome-mediated delivery of antisense oligonucleotides targeting C/EBPβ reprograms tumor-associated macrophages and induces potent single agent anti-tumor activity

Cancer research (Chicago, Ill.), 2022-06, Vol.82 (12_Supplement), p.3508-3508

2022

Volltextzugriff (PDF)

Systems biology driving drug development: from design to the clinical testing of the anti-ErbB3 antibody seribantumab (MM-121)

NPJ systems biology and applications, 2017-01, Vol.3 (1), p.16034-16034, Article 16034

2017

Volltextzugriff (PDF)

1 – 25 von 45

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(38)
Mit Volltextzugriff
(45)

Publikationsform

Artikel
(44)
Berichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Stress in the onset and aggravation of learning disabilities

The role of epigenetic mechanisms in the long‐term effects of early‐life adversity and mother–infant relationship on physiology and behavior of offspring in laboratory rats and mice

Effects of early social deprivation on epigenetic statuses and adaptive behavior of young children: A study based on a cohort of institutionalized infants and toddlers

Neuroendocrine and autonomic stress systems activity in young adults raised by mothers with mental health and substance abuse problems: A prospective cohort study

Effects of Early-Life Stress and HDAC Inhibition on Maternal Behavior in Mice

Associations between telomere length, glucocorticoid receptor gene DNA methylation, volume of stress-related brain structures, and academic performance in middle-school-age children

Endogenous Oxytocin and Human Social Interactions: A Systematic Review and Meta-Analysis

Objective Assessment of Temperament in Temperamentally Vulnerable Children: Role in the Studies on Their Stress Levels

Antitumor activity of MLN8054, an orally active small-molecule inhibitor of Aurora A kinase

Male pseudohermaphroditism: A case study of 46,XY disorder of sexual development using whole‐exome sequencing

Internet communication: architecture and typology of digital folklore

842 Exosome mediated reprogramming of tumor associated macrophages by exoASO-STAT6 for the treatment of hepatocellular carcinoma (HCC)

A versatile platform for generating engineered extracellular vesicles with defined therapeutic properties

Exosome-mediated genetic reprogramming of tumor-associated macrophages by exoASO-STAT6 leads to potent monotherapy antitumor activity

An ErbB3 Antibody, MM-121, Is Active in Cancers with Ligand-Dependent Activation

Abstract 1792: Engineered exosome- mediated STAT6 knockdown in tumor associated macrophages (TAMs) results in potent single agent activity in a hepatocellular carcinoma (HCC) model

Design of BET Inhibitor Bottlebrush Prodrugs with Superior Efficacy and Devoid of Systemic Toxicities

Abstract 5696: Genetic reprogramming of TAMs by engineered exosomes results in potent single agent anti-tumor activity

Enhanced Targeting of the EGFR Network with MM-151, an Oligoclonal Anti-EGFR Antibody Therapeutic

Antibody Drug Conjugates Targeted to CD45 or CD117 Enable Allogeneic Hematopoietic Stem Cell Transplantation in Animal Models

Abstract LB-243: The ErbB3-targeting antibody MM-121 (seribantumab) reverses heregulin-driven resistance to multiple chemotherapies on tumor cell growth

Abstract 2148: MM-151 elicits broad and unique inhibition of cells harboring EGFR extracellular domain mutations — results of multiscale experiments with genome-edited cell lines

Abstract LB-C25: Inhibition of ERBB3 with MM-121, IGF1-R with MM-141 or Met with MM-131 increases the activity of EGFR inhibitor MM-151 in colorectal cancer models expressing multiple resistance ligands

Abstract 3508: Exosome-mediated delivery of antisense oligonucleotides targeting C/EBPβ reprograms tumor-associated macrophages and induces potent single agent anti-tumor activity

Systems biology driving drug development: from design to the clinical testing of the anti-ErbB3 antibody seribantumab (MM-121)

Suchergebnisse filtern